US Light Therapy Market Research Report Forecast to 2030

The growth of the US light therapy market is attributed to the growing preference of patients toward non-invasive procedures, growing concern about mental health and rising demand for various depression therapies, and a rising number of strategic initiatives. However, side effects and risk associated with light therapy and lack of awareness among people is anticipated to hamper the market growth.

Light therapy, often known as phototherapy, is a method of medical care that uses artificial lighting. It is primarily used to treat seasonal affective disorder, a form of seasonal depression. This treatment compensates for the patient's lack of sun exposure, which is a leading cause of the disease. The light source simulates natural sunlight to assist with rehabilitation. Additionally, many different types of depression and sleep disorders are treated by light therapy. The amount of light utilized in treatment is determined using lux gauges, a unit of measurement.

Light therapy or phototherapy is a treatment type where the patient is exposed to an artificial light source. It mainly affects brain chemicals linked to mood and sleep, and also helps to reset the circadian rhythms, which control the sleep-wake cycle. This therapy is used in the treatment of various disorders, including depression, sleep disorders, jet lag, and Seasonal Affective Disorder (SAD). Factors such as the growing preference of patients toward non-invasive procedures are one of the major factors driving the growth of the light therapy market. Likewise, the rising number of strategic initiatives is further fueling the growth of the market during the review period. However, side effects and risk associated with light therapy is expected to hamper the growth of the light therapy market. Nevertheless, technological advancement in light therapy is anticipated to create lucrative opportunities for the players operating in the light therapy market.

Market Segmentation

Based on the product, the US light therapy market has been segmented into light box, floor & desk lamps, light visors, Handheld Devices for Skin Treatment (HDST), dawn simulators, light therapy bulbs, and others. The floor & desk lamps segment dominated the market in 2021.

Based on light type, the US light therapy market is segmented into white light, red light, blue light, and others. The blue light segment dominated the market in 2021.

On the basis of application, the US light therapy market is segmented into psoriasis, vitiligo, eczema, acne vulgaris, Seasonal Affective Disorder (SAD), sleeping disorders, fat loss, mood disorders, and others.

On the basis of end user, the US light therapy market is segmented into homecare settings, hospitals, dermatology clinics, and others. The hospitals segment dominated the market in 2021, while the dermatology clinics segment is projected to be the faster-growing segment during the forecast period.

Major Players

Koninklijke Philips N.V. (Germany), The Beurer Group (Germany), Biophotas (US), Lucimed SA (Belgium), PhotoMedex (US), and Nature Bright (US), Carex (US), and Zepter International (Switzerland).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 GROWING PREFERENCE OF PATIENTS TOWARD NON-INVASIVE PROCEDURES
- 4.2.2 GROWING CONCERN ABOUT MENTAL HEALTH AND RISING DEMAND FOR VARIOUS DEPRESSION THERAPIES
- 4.2.3 RISING NUMBER OF STRATEGIC INITIATIVES
4.3 RESTRAINTS
- 4.3.1 SIDE EFFECTS AND RISK ASSOCIATED WITH LIGHT THERAPY
- 4.3.2 LACK OF AWARENESS AMONG PEOPLE
4.4 OPPORTUNITIES
- 4.4.1 TECHNOLOGICAL ADVANCEMENT IN LIGHT THERAPY

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE US LIGHT THERAPY MARKET
- 5.3.1 IMPACT ON VALUE CHAIN
- 5.3.2 IMPACT ON SUPPLY CHAIN
- 5.3.3 IMPACT ON MARKET GROWTH
5.4 QUALITATIVE DATA ON LIGHT THERAPY FOR FAT-LOSS

6 US LIGHT THERAPY MARKET, BY PRODUCT

6.1 OVERVIEW

7 US LIGHT THERAPY MARKET, BY LIGHT TYPE

7.1 OVERVIEW

8 US LIGHT THERAPY MARKET, BY APPLICATION

8.1 OVERVIEW

9 US LIGHT THERAPY MARKET, BY END USER

9.1 OVERVIEW

10 COMPETITIVE LANDSCAPE

10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN US LIGHT THERAPY MARKET
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN US LIGHT THERAPY MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL
- 10.6.2 PARTNERSHIP/ COLLABORATION
- 10.6.3 EXPANSION/ AGREEMENT
10.7 MAJOR PLAYERS SALES ANALYSIS
10.8 MAJOR PLAYERS R&D ANALYSIS

11 COMPANY PROFILES

11.1 KONINKLIJKE PHILIPS N.V.
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS/SERVICES OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 NORTHERN LIGHT TECHNOLOGIES
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS/SERVICES OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 KEY STRATEGIES
11.3 VERILUX, INC.
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS/SERVICES OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 KEY STRATEGIES
11.4 THE BEURER GROUP
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS/SERVICES OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 THERALIGHT, LLC
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS/SERVICES OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 SWOT ANALYSIS
- 11.5.6 KEY STRATEGIES
11.6 CAREX
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 LUCIMED SA
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL OVERVIEW
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 KEY STRATEGIES
11.8 ZEPTER INTERNATIONAL
- 11.8.1 COMPANY OVERVIEWS
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 SWOT ANALYSIS
- 11.8.6 KEY STRATEGIES
11.9 PHOTOMEDEX
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL OVERVIEW
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 NATURE BRIGHT
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL OVERVIEW
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 KEY STRATEGIES
11.11 MEDISANA GMBH
- 11.11.1 COMPANY OVERVIEW
- 11.11.2 FINANCIAL OVERVIEW
- 11.11.3 PRODUCTS OFFERED
- 11.11.4 KEY DEVELOPMENTS
- 11.11.5 KEY STRATEGIES
11.12 LUMIE
- 11.12.1 COMPANY OVERVIEW
- 11.12.2 FINANCIAL OVERVIEW
- 11.12.3 PRODUCTS OFFERED
- 11.12.4 KEY DEVELOPMENTS
- 11.12.5 KEY STRATEGIES
11.13 BIOPHOTAS
- 11.13.1 COMPANY OVERVIEW
- 11.13.2 FINANCIAL OVERVIEW
- 11.13.3 PRODUCTS OFFERED
- 11.13.4 KEY DEVELOPMENTS
- 11.13.5 KEY STRATEGIES
11.14 JOHNSON & JOHNSON SERVICES, INC.
- 11.14.1 COMPANY OVERVIEWS
- 11.14.2 FINANCIAL OVERVIEW
- 11.14.3 PRODUCTS OFFERED
- 11.14.4 KEY DEVELOPMENTS
- 11.14.5 KEY STRATEGIES
11.15 NUSHAPE
- 11.15.1 COMPANY OVERVIEW
- 11.15.2 FINANCIAL OVERVIEW
- 11.15.3 PRODUCTS OFFERED
- 11.15.4 KEY DEVELOPMENTS
- 11.15.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17
TABLE 3 US: LIGHT THERAPY MARKET, BY PRODUCT, 2018-2030 (USD MILLION) 31
TABLE 4 US: LIGHT THERAPY MARKET, BY LIGHT TYPE, 2018-2030 (USD MILLION) 33
TABLE 5 US LIGHT THERAPY MARKET, BY APPLICATION, 2018-2030 (USD MILLION) 35
TABLE 6 US LIGHT THERAPY MARKET, BY END USER, 2018-2030 (USD MILLION) 37
TABLE 7 MAJOR MANUFACTURERS IN US LIGHT THERAPY MARKET 38
TABLE 8 MOST ACTIVE PLAYER IN LIGHT THERAPY MARKET 41
TABLE 9 PRODUCT LAUNCH/ PRODUCT APPROVAL 42
TABLE 10 PARTNERSHIP/ COLLABORATION 42
TABLE 11 EXPANSION/AGREEMENT 42
TABLE 12 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 46
TABLE 13 NORTHERN LIGHT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 48
TABLE 14 VERILUX, INC.: PRODUCTS/SERVICES OFFERED 50
TABLE 15 THE BEURER GROUP.: PRODUCTS/SERVICES OFFERED 52
TABLE 16 THERALIGHT, LLC.: PRODUCTS/SERVICES OFFERED 54
TABLE 17 THERALIGHT, LLC: KEY DEVELOPMENTS 54
TABLE 18 CAREX: PRODUCTS OFFERED 56
TABLE 19 LUCIMED SA: PRODUCTS OFFERED 59
TABLE 20 ZEPTER INTERNATIONAL: PRODUCTS OFFERED 61
TABLE 21 PHOTOMEDEX: PRODUCTS OFFERED 63
TABLE 22 NATURE BRIGHT: PRODUCTS OFFERED 64
TABLE 23 MEDISANA GMBH: PRODUCTS OFFERED 65
TABLE 24 LUMIE: PRODUCTS OFFERED 66
TABLE 25 BIOPHOTAS: PRODUCTS OFFERED 67
TABLE 26 BIOPHOTAS: KEY DEVELOPMENTS 68
TABLE 27 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 70
TABLE 28 NUSHAPE PRODUCTS OFFERED 72

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 11
FIGURE 2 US LIGHT THERAPY MARKET 13
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US LIGHT THERAPY MARKET 21
FIGURE 5 DRIVER IMPACT ANALYSIS 23
FIGURE 6 RESTRAINT IMPACT ANALYSIS 24
FIGURE 7 VALUE CHAIN ANALYSIS: US LIGHT THERAPY MARKET 25
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: US LIGHT THERAPY MARKET 27
FIGURE 9 US LIGHT THERAPY MARKET, BY PRODUCT, 2021 AND 2030 (USD MILLION) 31
FIGURE 10 US LIGHT THERAPY MARKET, BY LIGHT TYPE, 2021 AND 2030 (USD MILLION) 32
FIGURE 11 US LIGHT THERAPY MARKET, BY APPLICATION, 2021 AND 2030 (USD MILLION) 35
FIGURE 12 US LIGHT THERAPY MARKET, BY END USER, 2021 AND 2030 (USD MILLION) 37
FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS 39
FIGURE 14 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN US LIGHT THERAPY MARKET 40
FIGURE 15 US LIGHT THERAPY MARKET: COMPETITIVE LANDSCAPE 41
FIGURE 16 MAJOR PLAYERS SALES, 2021 43
FIGURE 17 MAJOR PLAYERS R&D, 2021 43
FIGURE 18 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT 45
FIGURE 19 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 47
FIGURE 20 THE BEURER GROUP: SWOT ANALYSIS 53
FIGURE 21 THERALIGHT, LLC.: SWOT ANALYSIS 55
FIGURE 22 CAREX: SWOT ANALYSIS 58
FIGURE 23 ZEPTER INTERNATIONAL: SWOT ANALYSIS 62
FIGURE 24 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 70